Lisa Johnson-Pratt

CIK: 0001849760

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ASPE

Aspen Neuroscience, Inc.

Officer

ASMB

ASSEMBLY BIOSCIENCES, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

ASMB
ASSEMBLY BIOSCIENCES, INC.
Jun 4, 2026
Award(A)
Stock Option (right to buy)
Direct
8K shares-
ASMB
ASSEMBLY BIOSCIENCES, INC.
Jun 5, 2025
Award(A)
Stock Option (right to buy)
Direct
3.5K shares-

		Type	Shares	Price		Ownership
Jun 4, 2026	ASMB ASSEMBLY BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	8,000	-	-	Direct
Jun 5, 2025	ASMB ASSEMBLY BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	3,500	-	-	Direct

1-2 of 2 transactions

About Johnson-Pratt Lisa

Johnson-Pratt Lisa (SEC CIK 0001849760) files insider reports with the SEC as Chief Commercial Officer of Aspen Neuroscience, Inc. (ASPE) and Director of ASSEMBLY BIOSCIENCES, INC. (ASMB).

Signal8 holds 3 ownership filings by Johnson-Pratt Lisa (1 Form 3, 2 Form 4), filed between Jun 9, 2025 and Oct 29, 2026. Those filings report 2 transactions, from Jun 5, 2025 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Johnson-Pratt Lisa's filings is in SAN DIEGO, CA.

Recent filings by Johnson-Pratt Lisa

Jun 4, 2026: Grant or award of ASMB derivative securities (Form 4, code A).
Jun 5, 2025: Grant or award of ASMB derivative securities (Form 4, code A).

Other insiders filing for Aspen Neuroscience, Inc. (ASPE)

ARCH Venture Fund X, L.P., 10% Owner
ARCH Venture Partners XIV, L.P., 10% Owner
Spaventa Andrew, Director
Hasnain Faheem, Executive Chair
ORBIMED ADVISORS LLC, Director
Boerneke Jeffrey Lee, General Counsel and Secretary

How to read Form 4 transaction codes